| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| ln Vitro |
ABT-089. Pozanicline is a partial agonist that acts on the α4β2 nAChR. Furthermore, with an EC50 of 0.11 μM, one α6β2 nAChR isoform is extremely sensitive to pozanicline [2]. The nAChR isoforms α6β2 and α4α5β2 are highly selective for pazanicline (ABT-089) [3].
|
|---|---|
| ln Vivo |
Deficits in contextual fear conditioning brought on by nicotine withdrawal are corrected by pozanicline (ABT-089; 0.3 mg/kg and 0.6 mg/kg) [3].
|
| Animal Protocol |
Animal/Disease Models: 8-12 weeks old adult male C57BL6/J mice [3].
Doses: 0.3 mg/kg and 0.6 mg/kg Route of Administration: Treatment was administered 5 minutes before training and testing contextual fear conditioning Experimental Results: Doses of 0.3 mg/kg and 0.6 mg/kg improved nicotine withdrawal-induced contextual fear conditioning aware of defects. |
| References |
|
| Molecular Formula |
C11H18CL2N2O
|
|---|---|
| Molecular Weight |
265.179420948029
|
| Exact Mass |
264.079
|
| CAS # |
161416-61-1
|
| Related CAS # |
Pozanicline;161417-03-4
|
| PubChem CID |
23729426
|
| Appearance |
White to off-white solid powder
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
16
|
| Complexity |
175
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
CC1=C(C=CC=N1)OC[C@@H]2CCCN2.Cl.Cl
|
| InChi Key |
UGVSESCRKJTJAK-XRIOVQLTSA-N
|
| InChi Code |
InChI=1S/C11H16N2O.2ClH/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10;;/h3,5-6,10,13H,2,4,7-8H2,1H3;2*1H/t10-;;/m0../s1
|
| Chemical Name |
2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine;dihydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~100 mg/mL (~377.10 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (377.10 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7710 mL | 18.8551 mL | 37.7102 mL | |
| 5 mM | 0.7542 mL | 3.7710 mL | 7.5420 mL | |
| 10 mM | 0.3771 mL | 1.8855 mL | 3.7710 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
